Search research articles
Contact Us
Filters
Showing results (531-540 of 566) with videos related to
Page
of 57
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 20, 2015
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
Andrew C Harris, Rachel Young, Steven Devine, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience
M Rimini, S Presi, K Mohammadi, et al.
The Lancet. Oncology
|
December 4, 2013
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial
Sung Won Choi, Thomas Braun, Lawrence Chang, et al.
Blood Advances
|
April 19, 2024
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
Zachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, et al.
Blood
|
March 28, 2015
The IL-33/ST2 axis augments effector T-cell responses during acute GVHD
Dawn K Reichenbach, Vincent Schwarze, Benjamin M Matta, et al.
HIV Medicine
|
June 25, 2020
Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort
L Taramasso, M Fabbiani, S Nozza, et al.
Transplantation and Cellular Therapy
|
March 28, 2024
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD
Muna Qayed, Urvi Kapoor, Scott Gillespie, et al.
Blood
|
September 12, 2022
Effective treatment of low-risk acute GVHD with itacitinib monotherapy
Aaron Etra, Alexandra Capellini, Amin Alousi, et al.
Blood Advances
|
July 1, 2025
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC
Yu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, et al.
Transplantation and Cellular Therapy
|
December 12, 2024
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group
Nikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, et al.
Page
of 57
Search research articles
Search
Showing results (531-540 of 566) with videos related to
Sort By:
Page
of 57
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 20, 2015
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
Andrew C Harris, Rachel Young, Steven Devine, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience
M Rimini, S Presi, K Mohammadi, et al.
The Lancet. Oncology
|
December 4, 2013
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial
Sung Won Choi, Thomas Braun, Lawrence Chang, et al.
Blood Advances
|
April 19, 2024
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
Zachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, et al.
Blood
|
March 28, 2015
The IL-33/ST2 axis augments effector T-cell responses during acute GVHD
Dawn K Reichenbach, Vincent Schwarze, Benjamin M Matta, et al.
HIV Medicine
|
June 25, 2020
Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort
L Taramasso, M Fabbiani, S Nozza, et al.
Transplantation and Cellular Therapy
|
March 28, 2024
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD
Muna Qayed, Urvi Kapoor, Scott Gillespie, et al.
Blood
|
September 12, 2022
Effective treatment of low-risk acute GVHD with itacitinib monotherapy
Aaron Etra, Alexandra Capellini, Amin Alousi, et al.
Blood Advances
|
July 1, 2025
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC
Yu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, et al.
Transplantation and Cellular Therapy
|
December 12, 2024
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group
Nikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, et al.
Page
of 57